DARZALEX 1800 MG SC SOLUTION FOR INJECTION, 1 PIECE - Turkey License 339787c015e9efcc42575cf83d8db7ff

Access comprehensive regulatory information for DARZALEX 1800 MG SC SOLUTION FOR INJECTION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 339787c015e9efcc42575cf83d8db7ff with license number 2022/798and contains active ingredient Daratumumab . The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.